Prophylactic human papillomavirus vaccines to prevent cervical cancer: review of the Phase II and III trials

ISSN： 1475-0708

Source： Therapy, Vol.5, Iss.3, 2008-05, pp. : 313-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Awareness of Turkish Nursing Students About Risk Factors for Cervical Cancer and Prophylactic Human Papillomavirus Vaccine

By Tas Fatma

Sexuality and Disability, Vol. 28, Iss. 4, 2010-12 ,pp. : 245-253

Springer Publishing Company

Access to resources Recommend Favorite

The human papillomavirus Test of Cure: A lesson on compliance with the NHMRC guidelines on screening to prevent cervical cancer

AUSTRALIAN AND NEW ZEALAND JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Vol. 55, Iss. 2, 2015-04 ,pp. : 185-190

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prophylactic human papillomavirus vaccine

By Paavonen Jorma Lehtinen Matti

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 5-6

Future Medicine

Access to resources Recommend Favorite

Primary human papillomavirus screening for cervical cancer in the United States—US Food and Drug Administration approval, clinical trials, and where we are today

CANCER CYTOPATHOLOGY, Vol. 122, Iss. 10, 2014-10 ,pp. : 720-729

John Wiley & Sons Inc

Access to resources Recommend Favorite

Further good news from prophylactic human papillomavirus vaccines: long-term duration of immunity

By Paolini Francesca Venuti Aldo

Women's Health, Vol. 6, Iss. 3, 2010-05 ,pp. : 361-363

Future Medicine

Access to resources Recommend Favorite